Getting the Right Evidence After Drug Approval

To generate comparative evidence in a timely fashion for drugs without restricting or delaying access, value-based pricing and reimbursement could be conditioned on a prospective, post-approval evidence generation plan.

Saved in:
Bibliographic Details
Main Authors: Rick A. Vreman (Author), Hubert G. M. Leufkens (Author), Aaron S. Kesselheim (Author)
Format: Book
Published: Frontiers Media S.A., 2020-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available